Vuity is a prescription eye drop used to treat presbyopia, an age-related condition that causes blurred near vision [1]. It is the first and only FDA-approved eye drop for this indication [2].
How does Vuity work?
Vuity contains the active ingredient pilocarpine hydrochloride, which is a muscarinic receptor agonist [1]. It works by constricting the pupil, which creates a pinhole effect. This increases the depth of focus, allowing for clearer vision at near and intermediate distances [3]. The effect of Vuity typically lasts for up to 6 hours [1].
When can I use Vuity eye drops?
Vuity is intended for daily use and can be administered once a day in each eye [1]. It is designed to help with activities like reading, using a computer, or seeing menus [4]. It is not intended for use in dim light conditions, as pupil constriction can worsen vision in low light [3].
What are the potential side effects of Vuity?
Common side effects of Vuity include headache and eye redness [1]. Other potential side effects can involve decreased vision in dim light, blurred vision, and eye strain [3]. Patients should not drive or operate machinery until they know how Vuity affects them [4].
How does Vuity compare to other presbyopia treatments?
Currently, Vuity is the only FDA-approved prescription eye drop for presbyopia. Other common treatments for presbyopia include reading glasses, bifocal or progressive contact lenses, and refractive surgery [2]. Vuity offers a non-invasive, drop-based alternative for managing blurred near vision [3].
When does the patent for Vuity expire?
Information regarding the specific patent expiry dates for Vuity (pilocarpine hydrochloride ophthalmic solution) is not readily available in the provided context but can typically be found through specialized patent tracking resources like DrugPatentWatch.com [5].
Who makes Vuity?
Vuity is developed and marketed by Allergan, an AbbVie company [2].